Literature DB >> 30816968

Beyond tissue concentrations: antifungal penetration at the site of infection.

Yanan Zhao1, Brendan Prideaux1, Shane Baistrocchi2, Donald C Sheppard2, David S Perlin1.   

Abstract

Despite advances in antifungal therapy, invasive fungal infections remain a significant cause of morbidity and mortality worldwide. One important factor contributing to the relative ineffectiveness of existing antifungal drugs is insufficient drug exposure at the site of infection. Despite the importance of this aspect of antifungal therapy, we generally lack a full appreciation of how antifungal drugs distribute, penetrate, and interact with their target organisms in different tissue subcompartments. A better understanding of drug distribution will be critical to guide appropriate use of currently available antifungal drugs, as well as to aid development of new agents. Herein we briefly review current perspectives of antifungal drug exposure at the site of infection and describe a new technique, matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging, which has the potential to greatly expand our understanding of drug penetration.
© The Author(s) 2019. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Entities:  

Keywords:  MALDI imaging; antifungals; drug quantification; posaconazole; site of infection; tissue penetration

Mesh:

Substances:

Year:  2019        PMID: 30816968      PMCID: PMC6506603          DOI: 10.1093/mmy/myy067

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  67 in total

1.  Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues.

Authors:  M Stoeckli; P Chaurand; D E Hallahan; R M Caprioli
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

Review 2.  Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions.

Authors:  A Vermes; H J Guchelaar; J Dankert
Journal:  J Antimicrob Chemother       Date:  2000-08       Impact factor: 5.790

3.  Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation.

Authors:  Sarah A Schwartz; Michelle L Reyzer; Richard M Caprioli
Journal:  J Mass Spectrom       Date:  2003-07       Impact factor: 1.982

4.  CHEMOTHERAPEUTIC ACTIVITY OF 5-FLUOROCYTOSINE.

Authors:  E GRUNBERG; E TITSWORTH; M BENNETT
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1963

5.  Fluorinated pyrimidines, a new class of tumour-inhibitory compounds.

Authors:  C HEIDELBERGER; N K CHAUDHURI; P DANNEBERG; D MOOREN; L GRIESBACH; R DUSCHINSKY; R J SCHNITZER; E PLEVEN; J SCHEINER
Journal:  Nature       Date:  1957-03-30       Impact factor: 49.962

6.  Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion.

Authors:  Helene Vogelsinger; Stefan Weiler; Angela Djanani; Jordan Kountchev; Rosa Bellmann-Weiler; Christian J Wiedermann; Romuald Bellmann
Journal:  J Antimicrob Chemother       Date:  2006-04-20       Impact factor: 5.790

7.  Phosphatidylcholine molecular species in lung surfactant: composition in relation to respiratory rate and lung development.

Authors:  W Bernhard; S Hoffmann; H Dombrowsky; G A Rau; A Kamlage; M Kappler; J J Haitsma; J Freihorst; H von der Hardt; C F Poets
Journal:  Am J Respir Cell Mol Biol       Date:  2001-12       Impact factor: 6.914

8.  Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.

Authors:  P J Paterson; S Seaton; H G Prentice; C C Kibbler
Journal:  J Antimicrob Chemother       Date:  2003-09-30       Impact factor: 5.790

9.  Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state.

Authors:  John E Conte; Jeffrey A Golden; Juliana Kipps; Marina McIver; Elisabeth Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 10.  The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety.

Authors:  Nathan P Wiederhold; James S Lewis
Journal:  Expert Opin Pharmacother       Date:  2007-06       Impact factor: 3.889

View more
  2 in total

Review 1.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

2.  How Long Do We Need to Treat an Invasive Mold Disease in Hematology Patients? Factors Influencing Duration of Therapy and Future Questions.

Authors:  Ana Fernández-Cruz; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.